Comparison of thyroid fine needle aspiration biopsy results before and after implementation of Bethesda classification.

OBJECTIVE: The Bethesda classification was introduced in 2008 to provide standardisation in the evaluation of thyroid fine needle aspiration cytology (FNAC). We compared the diagnostic value of pre-Bethesda and Bethesda classification systems in the differentiation of benign and malignant thyroid nodules. METHODS: Medical records of patients who underwent a thyroidectomy between June 2007 and June 2014 were reviewed retrospectively. Nodules evaluated with FNAC before March 2010 were classified as pre-Bethesda (non-diagnostic, benign, indeterminate, suspicious for malignancy and malignant), and those evaluated after March 2010 were considered Bethesda (non-diagnostic, benign, atypia of undetermined significance/follicular lesion of undetermined significance, follicular neoplasia/suspicious for follicular neoplasia, suspicious for malignancy and malignant). Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of the two classification systems were calculated. RESULTS: There were 1810 nodules in the pre-Bethesda and 5115 nodules in the Bethesda group. The non-diagnostic rate was significantly higher, and benign and suspicious for malignancy rates were lower in Bethesda compared with the pre-Bethesda group (P<.001 for each). When benign cytology was considered negative, and indeterminate, follicular neoplasia/suspicious for follicular neoplasia, suspicious for malignancy and malignant cytologies were considered positive, results for pre-Bethesda and Bethesda were as follows: sensitivity, 78.9% and 78.5%; specificity, 86.6% and 97.0%; PPV, 42.8% and 72.6%; NPV, 97% and 97.8%; and accuracy, 85.7% and 95.3%, respectively. CONCLUSIONS: Among operated nodules, percentages of benign and suspicious for malignancy cytologies decreased, and percentages of non-diagnostic and uncertain cytologies increased with the implementation of Bethesda. The diagnostic value of FNAC seems to have increased with the use of Bethesda classification.

Clinicopathological features of thyroid cancer in the elderly compared to younger counterparts: single-center experience.

PURPOSE: The incidence of thyroid cancer is increased in elderly patients. It tends to be larger and have more aggressive characteristics in these patients. Our aim was to compare features of thyroid carcinoma in geriatric and non-geriatric patients. METHODS: In total, 933 patients with thyroid cancer were retrospectively reviewed. Thyroid functions, ultrasonography features of malignant nodules, cytological and histopathological findings and the rates of recurrence and persistence were compared in patients ≥65 and <65 years old. RESULTS: There were 153 malignant foci in 109 (11.7%) patients ≥65 and 1185 malignant foci in 824 (88.3%) patients <65 years old. Mean nodule diameter was significantly higher in geriatric patients (p = 0.008). Most of the ultrasonographical features of malignant nodules were similar in two groups. Hypoechoic halo was observed in 16.4 and 28.6% of malignant nodules in geriatric and non-geriatric group, respectively (p = 0.034). There was no significant difference in cytological diagnosis. Histopathologically, tumor diameter, rates of microcarcinomas and incidentality were similar. Of all cancer types, 88.8% in geriatric and 93.9% in non-geriatric group were papillary thyroid cancer (p = 0.028). Hurthle cell cancer constituted 3.9 and 1.1% of carcinomas in geriatric and non-geriatric patients, respectively (p = 0.015); 2.0 and 0.2% of tumors in geriatric and non-geriatric group were anaplastic, respectively (p = 0.012). Capsular and vascular invasion, extrathyroidal extension, persistence and recurrence rates were similar. CONCLUSIONS: Rates of anaplastic cancer and Hurthle cell cancer which is known to have worser prognosis among other differentiated thyroid cancers are increased in geriatric ages. Cytological evaluation of thyroid nodules should strongly be considered due to increased tendency for aggressive tumor types in these patients.

The effect of carnitine on liver regeneration after partial hepatectomy.

AIM: The role of carnitine in liver regeneration. Can carnitine given externally increase and/or fasten the beginning of liver regeneration? RESULTS: Wistar Albino rats were used. Group 1: The group, which was applied parenteral carnitine after partial hepatectomy and sacrificed on the 1st day. Group 2: The group, which was applied parenteral carnitine after partial hepatectomy and sacrificed on the 7th day. Group 3: The group, which wasn't applied parenteral carnitine after partial hepatectomy and sacrificed in the 1st day. Group 4: The group which wasn't applied parenteral carnitne after partial hepatectomy and sacrificed on the 7th day. To all the rats, partial liver resection with the rate of 70 % was applied. Being started shortly after the resection, 100 mg/kg/day parenteral L-carnitine was applied to the first and second group. On the 1st and 7th days after the resection, eight subjects from each group were sacrificed. To evaluate the liver regeneration Ki-67 monoclonal antibody was used. After the examinations carried out by pathological clinic, detected mitosis number were examined. The 1st and 7th day mitosis number of the rats taken into the study was seen as statistically significantly higher than the mitosis number of the rats in the control group. CONCLUSIONS: As a result, among the rats, which were applied hepatectomy, if met by the major conditions triggering liver regeneration following the external carnitine supplementation, we can say with the help of the information provided by the study measuring the regeneration capacity by analysing Ki-67 proliferation index, that external carnitine support can increase the capacity of regeneration if it is given in appropriate dose (Tab. 6, Fig. 7, Ref. 17).